Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach
- PMID: 22477648
- PMCID: PMC3402568
- DOI: 10.1007/s12471-012-0268-8
Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach
Abstract
About 30 years ago, the first Dutch unifactorial guidelines on hypertension and hypercholesterolaemia were developed. These guidelines have been revised several times, often after publication of landmark studies on new generations of drugs. In 1978, cut-off points for pharmacological treatment of hypertension were based on diastolic blood pressure values ≥115 mmHg, and in 2000 they were lowered to >100 mmHg. From 1997 onwards, cut-off points for systolic blood pressure values >180 mmHg were introduced, which became leading. In 1987, cut-offs for hypercholesterolaemia of ≥8 mmol/l were set and from 2006 pharmacological treatment was based on a total/HDL cholesterol ratio >8. Around 2000, treatment decisions for hypertension and/or hypercholesterolaemia were no longer based on high levels of individual risk factors, but on a multifactorial approach based on total risk of cardiovascular diseases (CVD), determined by a risk function. In the 2006 multidisciplinary guideline on cardiovascular risk management, the Framingham risk tables were replaced by European SCORE risk charts. A cut-off point of 10% CVD mortality was set in the Netherlands. In 2011, this cut-off point changed to 20% fatal plus nonfatal CVD risk. Nowadays, 'the lower the risk factors, the lower the absolute risk' is the leading paradigm in CVD prevention.
Figures
Similar articles
-
Cardiovascular disease prevention: the new Joint British Societies' guidelines.Ann Clin Biochem. 2006 Sep;43(Pt 5):335-9. doi: 10.1258/000456306778520151. Ann Clin Biochem. 2006. PMID: 17022874
-
Cardiovascular risk assessment, cardiovascular disease risk factors, and lung function parameters.Kardiol Pol. 2018;76(7):1055-1063. doi: 10.5603/KP.a2018.0055. Epub 2018 Feb 5. Kardiol Pol. 2018. PMID: 29399756
-
Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis.Rheumatology (Oxford). 2016 Jul;55(7):1210-6. doi: 10.1093/rheumatology/kew039. Epub 2016 Mar 23. Rheumatology (Oxford). 2016. PMID: 27009825
-
Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.J Hum Hypertens. 1998 Sep;12(9):607-13. doi: 10.1038/sj.jhh.1000674. J Hum Hypertens. 1998. PMID: 9783489 Review.
-
[CBO guideline 'High blood pressure' (revision)].Ned Tijdschr Geneeskd. 2001 Oct 27;145(43):2071-6. Ned Tijdschr Geneeskd. 2001. PMID: 11715592 Review. Dutch.
Cited by
-
Heart disease in the Netherlands: a quantitative update.Neth Heart J. 2014 Jan;22(1):3-10. doi: 10.1007/s12471-013-0504-x. Neth Heart J. 2014. PMID: 24343132 Free PMC article.
-
CVON: a laudable strategy waiting for societal impact.Neth Heart J. 2015 Apr;23(4):197-8. doi: 10.1007/s12471-015-0672-y. Neth Heart J. 2015. PMID: 25884089 Free PMC article. No abstract available.
-
Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.Sci Rep. 2017 Mar 7;7(1):106. doi: 10.1038/s41598-017-00205-9. Sci Rep. 2017. PMID: 28273891 Free PMC article. Clinical Trial.
-
Prevalence of psychological distress in elderly hypertension patients in primary care.Neth Heart J. 2014 Feb;22(2):71-6. doi: 10.1007/s12471-013-0502-z. Neth Heart J. 2014. PMID: 24307378 Free PMC article.
-
Should non-cardiovascular mortality be considered in the SCORE model? Findings from the Prevention of Renal and Vascular End-stage Disease (PREVEND) cohort.Eur J Epidemiol. 2015 Jan;30(1):47-56. doi: 10.1007/s10654-014-9967-3. Epub 2014 Nov 7. Eur J Epidemiol. 2015. PMID: 25377534
References
-
- Interim advice on hypertension. Health Council, The Hague, 1978/18.
-
- Advice on hypertension. Health Council, The Hague, 1983/2.
-
- Cholesterol. Health Council, The Hague, 1990/1.
-
- Consensus diagnostics and treatment of hypertension. Hart Bulletin 1990;21:142–210.
-
- Cholesterol consensus. Hart Bulletin supplement 1987;1:3–64.
LinkOut - more resources
Full Text Sources